2.01 (-%)
As of Dec 06, 2024
Source:
Hillevax, Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | ( 617 ) 213-5054 |
Industry | manufacturing |
CEO | Robert Hershberg |
Website | www.hillevax.com |